Citrine S A L

About

Portfolio

Investment activity

Q&A

What is Citrine S A L's primary investment focus?

Citrine S A L is a technology-focused investment group that enables Israeli entrepreneurs to materialize global breakthrough technology companies. They manage funds specializing in cleantech/green energy, cyber-technology, blockchain, media, IoT, HW & SW, as well as biotech, medical devices, digital health, and cannabis solutions.

When was Citrine S A L founded?

Citrine S A L was founded in 2015.

Who are the co-founders and general partners of Citrine S A L?

The co-founders and general partners of Citrine S A L are Ora Meir-Soffer and Yaron Pitaru.

What is Citrine S A L's geographic focus for investments?

Citrine S A L focuses on enabling Israeli entrepreneurs to materialize global breakthrough technology companies, indicating a primary focus on Israeli startups with global aspirations.

What is the total amount Citrine S A L has raised from Israeli private investors?

Citrine S A L has raised over $300M from Israeli private investors, setting up 70 partnerships in various fields.

What is Citrine S A L's target for managed assets in the next seven years?

Citrine S A L targets to manage $1 billion for private and international investors in the next seven years.

Which sectors does Citrine S A L's portfolio primarily concentrate on?

Citrine S A L's portfolio shows a concentration in the Health Tech & Life Sciences sector, with all four recorded portfolio companies falling into this category.

Can you name a notable portfolio company and its investment stage?

One notable portfolio company is TechCare, which was acquired and had raised $1.8M. Another is ImProDia, which received a Seed investment of $200K.